PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
Authors:
Open Access
- 1 January 2009
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 89 (1) , 47-58
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Amelioration of anti-Thy1-glomerulonephritis by PPAR-γ agonism without increase of endothelial progenitor cell homingAmerican Journal of Physiology-Renal Physiology, 2008
- Protective Effects of Peroxisome Proliferator-Activated Receptor γ Ligand on Apoptosis and Hepatocyte Growth Factor Induction in Renal Ischemia-Reperfusion InjuryTransplantation, 2007
- Transcriptional Regulation of Nephrin Gene by Peroxisome Proliferator–Activated Receptor-γ AgonistJournal of the American Society of Nephrology, 2006
- PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activationClinical and Experimental Immunology, 2006
- The effect of high glucose and PPAR-γ agonists on PPAR-γ expression and function in HK-2 cellsAmerican Journal of Physiology-Renal Physiology, 2004
- Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responsesKidney International, 2004
- c-Fos-driven transcriptional activation of transforming growth factor β-1: inhibition of high glucose-induced promoter activity by thiazolidinedionesBiochemical and Biophysical Research Communications, 2003
- Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidneyKidney International, 2003
- Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)? activatorsClinical and Experimental Nephrology, 2003
- Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in ratsKidney International, 2001